IL17A and juvenile idiopathic arthritis: In contrast, the number of IL-17+,CD4+ T cells in SFMCs was significantly increased (median 1.2%; IQR 0.7–2.6) as compared with that in PBMCs from both the JIA patients (P = 0.0001) and the controls (P = 0.018) (Figure 1B).